Hence, elucidating the role of PKC and the effects of PKC modulators on CM hypertrophy will not only facilitate the development of novel therapies to cardiac diseases, but will also give insight into the cardiac effects of PKC modulators developed for other applications, such as for the treatment of cancer. This evidence concerns the gene PRRT2 and heart disorder.